Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer (IMMC-06)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00133913|
Recruitment Status : Unknown
Verified March 2008 by Immunicon.
Recruitment status was: Active, not recruiting
First Posted : August 24, 2005
Last Update Posted : March 19, 2008
|Condition or disease||Intervention/treatment|
|Colorectal Cancer Neoplasm Metastasis||Procedure: Phlebotomy|
|Study Type :||Observational|
|Actual Enrollment :||486 participants|
|Official Title:||Longitudinal Enumeration of Circulating Tumor Cells in Patients With Metastatic Colorectal Carcinomas|
|Study Start Date :||March 2004|
|Actual Primary Completion Date :||January 2007|
|Estimated Study Completion Date :||January 2009|
Patients with measurable metastatic colorectal cancer about to start a new line of chemotherapy.
Peripheral blood draws for testing of circulating tumor cells
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00133913
|United States, Pennsylvania|
|Fox Chase Cancer Center|
|Philadelphia, Pennsylvania, United States, 19111|
|Principal Investigator:||Steven Cohen, MD||Fox Chase Cancer Center|